Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000004389 | SCV001227026 | pathogenic | Schimke immuno-osseous dysplasia | 2024-02-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg17*) in the SMARCAL1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMARCAL1 are known to be pathogenic (PMID: 11799392, 20301550). This variant is present in population databases (rs119473034, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Schimke immuno-osseous dysplasia (PMID: 11799392). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 4172). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000004389 | SCV002791511 | pathogenic | Schimke immuno-osseous dysplasia | 2021-12-06 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000004389 | SCV000024561 | pathogenic | Schimke immuno-osseous dysplasia | 2002-02-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000004389 | SCV002076271 | pathogenic | Schimke immuno-osseous dysplasia | 2021-05-04 | no assertion criteria provided | clinical testing |